TP53 and colonic neoplasm: Accordingly, as presented in Table 1, seven chalcones were selected based on their promising anticancer activity profile for further evaluation in two additional colon cancer cell lines: HCT116 p53+/+ (with wild-type p53) and HCT116 p53−/− (isogenic cells lacking p53) (Table 2).